Abstract

Aims: Paediatric massive transfusion protocol (MTP) in our institution was introduced in 2013. It is divided into 4 codes based on patient’s weight, which upon activation, facilitate the timely provision of red cells, platelets and plasma in a predetermined ratio. We aimed to review the response time, blood product usage and wastage from MTP activations in our institution. Methods: Transfusion records of paediatric requiring MTP activations from 2013 to 2015 in our institution were reviewed retrospectively. Results: There were a total of 12 MTP activations since 2013. Median response time was 10 minutes (range 6 to >1 hr). MTP was ceased in cycle 1 for 8% of the patients, cycle 2 for 42%, cycle 3 for 33% and beyond cycle 3 for 8%. There were 8% of patients who did not fully utilise the blood products within cycle 1. 2 units of red cells, 1 unit of platelet and 1 unit of plasma were wasted in the 12 MTP activations. Discussion: Paediatric MTP allows the provision of suitable blood products to bleeding patients. There is a need to fine-tune the activation protocol to reduce response time and blood wastage. Blood products within the MTP may be modified to include cryoprecipitate, to better support bleeding emergencies.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call